Feedback / Questions
VET3-TGI - KaliVir
https://www.businesswire.com/news/home/20250520615879/en/KaliVir-Immunotherapeutics-Announces-Completion-of-First-Cohort-of-STEALTH-001-Study-Evaluating-VET3-TGI-in-Patients-with-Advanced-Solid-Tumors
May 20, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next